BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31147931)

  • 1. Peptide Trimming for MHC Class I Presentation by Endoplasmic Reticulum Aminopeptidases.
    Compagnone M; Fruci D
    Methods Mol Biol; 2019; 1988():45-57. PubMed ID: 31147931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimming of MHC Class I Ligands by ERAP Aminopeptidases.
    Weimershaus M; Evnouchidou I; Li L; van Endert P; Bouvier M
    Methods Mol Biol; 2019; 1988():31-43. PubMed ID: 31147930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum.
    Saveanu L; Carroll O; Lindo V; Del Val M; Lopez D; Lepelletier Y; Greer F; Schomburg L; Fruci D; Niedermann G; van Endert PM
    Nat Immunol; 2005 Jul; 6(7):689-97. PubMed ID: 15908954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.
    Li L; Batliwala M; Bouvier M
    J Biol Chem; 2019 Dec; 294(49):18534-18544. PubMed ID: 31601650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The partial dissociation of MHC class I-bound peptides exposes their N terminus to trimming by endoplasmic reticulum aminopeptidase 1.
    Papakyriakou A; Reeves E; Beton M; Mikolajek H; Douglas L; Cooper G; Elliott T; Werner JM; James E
    J Biol Chem; 2018 May; 293(20):7538-7548. PubMed ID: 29599287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental leucine aminopeptidase efficiently generates mature antigenic peptides in vitro but in patterns distinct from endoplasmic reticulum aminopeptidase 1.
    Georgiadou D; Hearn A; Evnouchidou I; Chroni A; Leondiadis L; York IA; Rock KL; Stratikos E
    J Immunol; 2010 Aug; 185(3):1584-92. PubMed ID: 20592285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ERAP1 and ERAP2 gene polymorphisms on disease susceptibility in different populations.
    Yao Y; Liu N; Zhou Z; Shi L
    Hum Immunol; 2019 May; 80(5):325-334. PubMed ID: 30797823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of ERAP1 and ERAP2 genes and their disfunction in human cancer.
    Compagnone M; Cifaldi L; Fruci D
    Hum Immunol; 2019 May; 80(5):318-324. PubMed ID: 30825518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of endoplasmic reticulum aminopeptidases in EBV-B cell lines from healthy donors and in leukemia/lymphoma, carcinoma, and melanoma cell lines.
    Fruci D; Ferracuti S; Limongi MZ; Cunsolo V; Giorda E; Fraioli R; Sibilio L; Carroll O; Hattori A; van Endert PM; Giacomini P
    J Immunol; 2006 Apr; 176(8):4869-79. PubMed ID: 16585582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERAP1 shapes just part of the immunopeptidome.
    Admon A
    Hum Immunol; 2019 May; 80(5):296-301. PubMed ID: 30849449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common allotypes of ER aminopeptidase 1 have substrate-dependent and highly variable enzymatic properties.
    Hutchinson JP; Temponeras I; Kuiper J; Cortes A; Korczynska J; Kitchen S; Stratikos E
    J Biol Chem; 2021; 296():100443. PubMed ID: 33617882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ERAP1-ERAP2 dimerization increases peptide-trimming efficiency.
    Evnouchidou I; Weimershaus M; Saveanu L; van Endert P
    J Immunol; 2014 Jul; 193(2):901-8. PubMed ID: 24928998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
    Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
    Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ER Aminopeptidases, ERAP1 and ERAP2, synergize to self-modulate their respective activities.
    Martín-Esteban A; Rodriguez JC; Peske D; Lopez de Castro JA; Shastri N; Sadegh-Nasseri S
    Front Immunol; 2022; 13():1066483. PubMed ID: 36569828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The specificity of trimming of MHC class I-presented peptides in the endoplasmic reticulum.
    Hearn A; York IA; Rock KL
    J Immunol; 2009 Nov; 183(9):5526-36. PubMed ID: 19828632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum aminopeptidases: Biology and pathogenic potential.
    Haroon N; Inman RD
    Nat Rev Rheumatol; 2010 Aug; 6(8):461-7. PubMed ID: 20531381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationally designed inhibitor targeting antigen-trimming aminopeptidases enhances antigen presentation and cytotoxic T-cell responses.
    Zervoudi E; Saridakis E; Birtley JR; Seregin SS; Reeves E; Kokkala P; Aldhamen YA; Amalfitano A; Mavridis IM; James E; Georgiadis D; Stratikos E
    Proc Natl Acad Sci U S A; 2013 Dec; 110(49):19890-5. PubMed ID: 24248368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shedding new light on the role of ERAP1 in Type 1 diabetes: A perspective on disease management.
    Paldino G; Fierabracci A
    Autoimmun Rev; 2023 Apr; 22(4):103291. PubMed ID: 36740089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular antigen processing by ERAP2: Molecular mechanism and roles in health and disease.
    de Castro JAL; Stratikos E
    Hum Immunol; 2019 May; 80(5):310-317. PubMed ID: 30414458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ERAP1 in autoinflammation and autoimmunity.
    Pepelyayeva Y; Amalfitano A
    Hum Immunol; 2019 May; 80(5):302-309. PubMed ID: 30817945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.